GILD

Gilead Sciences, Inc. News Headlines

$69.28
*  
1.11
 negative 
1.63%
Get GILD Alerts
*Delayed - data as of Apr. 16, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Rolling The Dice With Earnings
4/16/2014 5:29:00 PM - Seeking Alpha

Gilead Sciences May See A Healthy Earnings Beat
4/16/2014 1:35:00 PM - Seeking Alpha

Gilead: This Baby Has Been Thrown Away With The Bathwater
4/16/2014 8:50:00 AM - Seeking Alpha

Bristol-Myers Seeks Approval for HIV Combo Drug - Analyst Blog
4/15/2014 6:30:01 PM - Zacks.com

Sales of Johnson's New Hepatitis Drug Soars
4/15/2014 1:15:00 PM - Dow Jones Business News

Sales of Johnson & Johnson's New Hepatitis Drug Soars
4/15/2014 12:55:00 PM - Dow Jones Business News

Sales of Johnson s New Hepatitis Drug Soars
4/15/2014 12:55:00 PM - Dow Jones Business News

S&P 500 Movers: NEM, TRIP
4/15/2014 11:43:56 AM - BNK Invest

Hard-to-Cure Patients May Benefit from Merck's HCV Drug - Analyst Blog
4/14/2014 5:10:01 PM - Zacks.com

Positive Data on AbbVie's HCV Program - Analyst Blog
4/14/2014 4:50:01 PM - Zacks.com

Gilead Sciences' Solvadi Is A Game Changer
4/14/2014 4:26:00 PM - Seeking Alpha

Markets Falling? Get Your Defense Ready
4/14/2014 2:47:00 PM - Investopedia

Gilead Bucks Biotech Trend Thanks to Sovaldi News - Analyst Blog
4/14/2014 11:30:01 AM - Zacks.com

Investment Implications Of The Trash Crash: Don't Panic, Don't Kid Yourself, Be Disciplined
4/14/2014 10:34:00 AM - Seeking Alpha

Pre-Market Most Active for Apr 14, 2014 : C, ING, BAC, FB, QQQ, ALU, TVIX, BCS, NBG, XIV, ASML, GILD
4/14/2014 8:39:56 AM - NASDAQ.com News

Reevaluating Gilead Sciences After The Sell-Off
4/14/2014 8:38:00 AM - Seeking Alpha

Bristol-Myers Submits NDA For Combination Tablet Of Atazanavir With Cobicistat
4/14/2014 8:14:00 AM - RTT News

Encouraging Results on Gilead's Sovaldi - Analyst Blog
4/11/2014 5:15:01 PM - Zacks.com

3 Pharma Mutual Funds Beating the S&P 500 - Best of Funds
4/11/2014 3:45:01 PM - Zacks.com

Sector Update: Healthcare
4/11/2014 3:02:16 PM - MT Newswires

Sector Update: Healthcare Mixed in Late Session; Gilead Sciences Turns Higher
4/11/2014 3:00:08 PM - MT Newswires

Encouraging Data from Bristol-Myers - Analyst Blog
4/11/2014 11:30:01 AM - Zacks.com

Today's Market: Playing The Biotech Bloodbath
4/11/2014 10:49:00 AM - Seeking Alpha

Gilead Sciences (GILD) Falls: Stock Goes Down 7.3% - Tale of the Tape
4/11/2014 9:00:01 AM - Zacks.com

3 Biotech Companies That Look To Be Good Buys After A Pullback
4/11/2014 8:32:00 AM - Seeking Alpha